UB Paderborn / Katalog / Suche / in CDI

Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials

The Lancet (British edition), 2007-05, Vol.369 (9574), p.1693-1702

2007

Volltextzugriff (PDF)

Safety and efficacy of the pentavalent human-bovine (WC3) reassortant rotavirus vaccine in healthy premature infants

The Pediatric infectious disease journal, 2007-12, Vol.26 (12), p.1099-1104

2007

Volltextzugriff (PDF)

Efficacy, immunogenicity, and safety of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine at the end of shelf life

Pediatrics (Evanston), 2007-01, Vol.119 (1), p.11-18

2007

Volltextzugriff (PDF)

Profile: PATH's Vaccine Development Global Program

Human vaccines & immunotherapeutics, 2012-06, Vol.8 (6), p.700-701

Boslego, John W.

2012

Volltextzugriff (PDF)

Safety and immunogenicity of a parenterally administered rotavirus VP8 subunit vaccine in healthy adults

Vaccine, 2015-07, Vol.33 (31), p.3766-3772

2015

Volltextzugriff (PDF)

Safety and Efficacy of a Pentavalent Human–Bovine (WC3) Reassortant Rotavirus Vaccine

The New England journal of medicine, 2006-01, Vol.354 (1), p.23-33

2006

Volltextzugriff (PDF)

Safety, tolerability and immunogenicity of a recombinant hepatitis B vaccine manufactured by a modified process in healthy young adults

Human vaccines, 2009-02, Vol.5 (2), p.92-97

2009

Volltextzugriff (PDF)

PATH Influenza Vaccine Project: accelerating the development of new influenza vaccines for low-resource countries

Expert review of vaccines, 2012-08, Vol.11 (8), p.939-947

2012

Volltextzugriff (PDF)

Concomitant use of an oral live pentavalent human-bovine reassortant rotavirus vaccine with licensed parenteral pediatric vaccines in the United States

The Pediatric infectious disease journal, 2007-03, Vol.26 (3), p.221-227

2007

Volltextzugriff (PDF)

Safety and immunogenicity of three different formulations of a liquid hexavalent diphtheria–tetanus–acellular pertussis–inactivated poliovirus– Haemophilus influenzae b conjugate–hepatitis B vaccine at 2, 4, 6 and 12–14 months of age

Vaccine, 2011-02, Vol.29 (6), p.1324-1331

2011

Volltextzugriff (PDF)

Safety and immunogenicity of a hexavalent diphtheria–tetanus–acellular pertussis–inactivated poliovirus– Haemophilus influenzae b conjugate–hepatitis B vaccine at 2, 3, 4, and 12–14 months of age

Vaccine, 2009-04, Vol.27 (19), p.2540-2547

2009

Volltextzugriff (PDF)

Protection against hepatitis A by an inactivated vaccine

JAMA : the journal of the American Medical Association, 1994-05, Vol.271 (17), p.1328

1994

Volltextzugriff (PDF)

Experimental Gonococcal Urethritis and Reinfection with Homologous Gonococci in Male Volunteers

Sexually transmitted diseases, 2001-10, Vol.28 (10), p.555-564

2001

Volltextzugriff (PDF)

Strategies for broad global access to pandemic influenza vaccines

Current topics in microbiology and immunology, 2009, Vol.333, p.471

2009

Volltextzugriff (PDF)

Path Pneumococcal Vaccine Project

Pediatric health, 2010-10, Vol.4 (5), p.471-478

2010

Volltextzugriff (PDF)

Post-licensure comparative study of unusual high-pitched crying and prolonged crying following COMVAX™ and placebo versus PedvaxHIB™ and RECOMBIVAX HB™ in healthy infants

Vaccine, 2002-12, Vol.21 (3), p.181-187

2002

Volltextzugriff (PDF)

Group B streptococcal vaccine for resource-poor countries

The Lancet (British edition), 2011-07, Vol.378 (9785), p.11-12

Schrag, Stephanie J

2011

Volltextzugriff (PDF)

Effect of spectinomycin use on the prevalence of spectinomycin-resistant and of penicillinase-producing Neisseria gonorrhoeae

The New England journal of medicine, 1987-07, Vol.317 (5), p.272-278

1987

Volltextzugriff (PDF)

Inflammatory cytokines produced in response to experimental human gonorrhea

The Journal of infectious diseases, 1995-07, Vol.172 (1), p.186-191

1995

Volltextzugriff (PDF)

Safety and immunogenicity of a hexavalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzaeb conjugate-hepatitis B vaccine at 2, 3, 4, and 12-14 months of age

Vaccine, 2009-04, Vol.27 (19), p.2540

2009

Volltextzugriff (PDF)

Expression of paragloboside-like lipooligosaccharides may be a necessary component of gonococcal pathogenesis in men

The Journal of experimental medicine, 1991-12, Vol.174 (6), p.1601-1605

1991

Volltextzugriff (PDF)

Experimental human gonococcal urethritis: 250 Neisseria gonorrhoeae MS11mkC are infective

The Journal of infectious diseases, 1995-07, Vol.172 (1), p.180-185

1995

Volltextzugriff (PDF)

Efficacy trial of a parenteral gonococcal pilus vaccine in men

Vaccine, 1991-03, Vol.9 (3), p.154-162

1991

Volltextzugriff (PDF)

Spectinomycin and resistant Neisseria gonorrhoeae

The New England journal of medicine, 1988-02, Vol.318 (5), p.325-326

1988

Volltextzugriff (PDF)

A general approach to standardization of the solid-phase radioimmunoassay for quantitation of class-specific antibodies

Journal of immunological methods, 1981-01, Vol.46 (2), p.129-140

1981

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials

Safety and efficacy of the pentavalent human-bovine (WC3) reassortant rotavirus vaccine in healthy premature infants

Efficacy, immunogenicity, and safety of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine at the end of shelf life

Profile: PATH's Vaccine Development Global Program

Safety and immunogenicity of a parenterally administered rotavirus VP8 subunit vaccine in healthy adults

Safety and Efficacy of a Pentavalent Human–Bovine (WC3) Reassortant Rotavirus Vaccine

Safety, tolerability and immunogenicity of a recombinant hepatitis B vaccine manufactured by a modified process in healthy young adults

PATH Influenza Vaccine Project: accelerating the development of new influenza vaccines for low-resource countries

Concomitant use of an oral live pentavalent human-bovine reassortant rotavirus vaccine with licensed parenteral pediatric vaccines in the United States

Safety and immunogenicity of three different formulations of a liquid hexavalent diphtheria–tetanus–acellular pertussis–inactivated poliovirus– Haemophilus influenzae b conjugate–hepatitis B vaccine at 2, 4, 6 and 12–14 months of age

Safety and immunogenicity of a hexavalent diphtheria–tetanus–acellular pertussis–inactivated poliovirus– Haemophilus influenzae b conjugate–hepatitis B vaccine at 2, 3, 4, and 12–14 months of age

Protection against hepatitis A by an inactivated vaccine

Experimental Gonococcal Urethritis and Reinfection with Homologous Gonococci in Male Volunteers

Strategies for broad global access to pandemic influenza vaccines

Path Pneumococcal Vaccine Project

Post-licensure comparative study of unusual high-pitched crying and prolonged crying following COMVAX™ and placebo versus PedvaxHIB™ and RECOMBIVAX HB™ in healthy infants

Group B streptococcal vaccine for resource-poor countries

Effect of spectinomycin use on the prevalence of spectinomycin-resistant and of penicillinase-producing Neisseria gonorrhoeae

Inflammatory cytokines produced in response to experimental human gonorrhea

Safety and immunogenicity of a hexavalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzaeb conjugate-hepatitis B vaccine at 2, 3, 4, and 12-14 months of age

Expression of paragloboside-like lipooligosaccharides may be a necessary component of gonococcal pathogenesis in men

Experimental human gonococcal urethritis: 250 Neisseria gonorrhoeae MS11mkC are infective

Efficacy trial of a parenteral gonococcal pilus vaccine in men

Spectinomycin and resistant Neisseria gonorrhoeae

A general approach to standardization of the solid-phase radioimmunoassay for quantitation of class-specific antibodies

Suchergebnisse filtern